INOVIO PHARMACEUTICALS, INC.: 10-K filed 2018-03-14

Name: INOVIO PHARMACEUTICALS, INC.: 10-K filed 2018-03-14
Creator: INOVIO PHARMACEUTICALS, INC.

What INOVIO PHARMACEUTICALS, INC. reported in its annual report filed 2018-03-14 (fiscal FY 2017): 49 published measures, 192 facts as tagged in accession 0001055726-18-000014.

This filing

Form: 10-K (annual report)
Filed: 2018-03-14
Fiscal period: fiscal FY 2017
Accession: 0001055726-18-000014 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-12-31	187,239,270	USD
At 2016-12-31	173,707,166	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-12-31	44,750,461	USD
At 2016-12-31	50,328,746	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-12-31	142,392,540	USD
At 2016-12-31	123,282,151	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-12-31	23,786,579	USD
At 2016-12-31	19,136,472	USD
At 2015-12-31	57,632,693	USD
At 2014-12-31	40,543,982	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-21,506,179	USD	92
2017-01-01 to 2017-12-31	-88,205,772	USD	365
2017-07-01 to 2017-09-30	-34,134,570	USD	92
2017-04-01 to 2017-06-30	-9,479,116	USD	91
2017-01-01 to 2017-03-31	-23,085,907	USD	90
2016-10-01 to 2016-12-31	-26,233,470	USD	92
2016-01-01 to 2016-12-31	-73,740,339	USD	366
2016-07-01 to 2016-09-30	-20,759,338	USD	92
2016-04-01 to 2016-06-30	-18,704,711	USD	91
2016-01-01 to 2016-03-31	-8,042,820	USD	91
2015-01-01 to 2015-12-31	-29,187,606	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-63,208,921	USD	365
2016-01-01 to 2016-12-31	-62,555,052	USD	366
2015-01-01 to 2015-12-31	-12,438,901	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	10,293,902	USD	365
2016-01-01 to 2016-12-31	2,738,470	USD	366
2015-01-01 to 2015-12-31	2,781,544	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	8,787,234	USD	92
2017-01-01 to 2017-12-31	42,220,086	USD	365
2017-07-01 to 2017-09-30	2,644,543	USD	92
2017-04-01 to 2017-06-30	20,412,124	USD	91
2017-01-01 to 2017-03-31	10,376,185	USD	90
2016-10-01 to 2016-12-31	8,513,952	USD	92
2016-01-01 to 2016-12-31	35,368,361	USD	366
2016-07-01 to 2016-09-30	12,540,463	USD	92
2016-04-01 to 2016-06-30	6,203,791	USD	91
2016-01-01 to 2016-03-31	8,110,155	USD	91
2015-01-01 to 2015-12-31	40,572,111	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	95,690,172	USD	365
2016-01-01 to 2016-12-31	7,786,942	USD	366
2015-01-01 to 2015-12-31	84,351,719	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-27,831,144	USD	365
2016-01-01 to 2016-12-31	16,271,889	USD	366
2015-01-01 to 2015-12-31	-54,824,107	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-12-31	-523,356,317	USD
At 2016-12-31	-434,838,235	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	81,777,493	shares	365
2016-01-01 to 2016-12-31	73,214,766	shares	366
2015-01-01 to 2015-12-31	68,198,142	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	81,918,022	shares	365
2016-01-01 to 2016-12-31	73,214,766	shares	366
2015-01-01 to 2015-12-31	68,365,265	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-0.24	USD/shares	92
2017-01-01 to 2017-12-31	-1.08	USD/shares	365
2017-07-01 to 2017-09-30	-0.39	USD/shares	92
2017-04-01 to 2017-06-30	-0.13	USD/shares	91
2017-01-01 to 2017-03-31	-0.31	USD/shares	90
2016-10-01 to 2016-12-31	-0.35	USD/shares	92
2016-01-01 to 2016-12-31	-1.01	USD/shares	366
2016-07-01 to 2016-09-30	-0.28	USD/shares	92
2016-04-01 to 2016-06-30	-0.26	USD/shares	91
2016-01-01 to 2016-03-31	-0.11	USD/shares	91
2015-01-01 to 2015-12-31	-0.43	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-0.24	USD/shares	92
2017-01-01 to 2017-12-31	-1.09	USD/shares	365
2017-07-01 to 2017-09-30	-0.4	USD/shares	92
2017-04-01 to 2017-06-30	-0.13	USD/shares	91
2017-01-01 to 2017-03-31	-0.31	USD/shares	90
2016-10-01 to 2016-12-31	-0.36	USD/shares	92
2016-01-01 to 2016-12-31	-1.01	USD/shares	366
2016-07-01 to 2016-09-30	-0.28	USD/shares	92
2016-04-01 to 2016-06-30	-0.26	USD/shares	91
2016-01-01 to 2016-03-31	-0.11	USD/shares	91
2015-01-01 to 2015-12-31	-0.44	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	0	USD	365
2016-01-01 to 2016-12-31	0	USD	366
2015-01-01 to 2015-12-31	-2,097,766	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-12-31	18,320,176	USD
At 2016-12-31	9,025,446	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	13,070,962	USD	365
2016-01-01 to 2016-12-31	10,479,135	USD	366
2015-01-01 to 2015-12-31	6,186,848	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-22,887,789	USD	92
2017-01-01 to 2017-12-31	-83,642,901	USD	365
2017-07-01 to 2017-09-30	-29,185,471	USD	92
2017-04-01 to 2017-06-30	-9,635,733	USD	91
2017-01-01 to 2017-03-31	-21,933,908	USD	90
2016-10-01 to 2016-12-31	-22,363,296	USD	92
2016-01-01 to 2016-12-31	-76,235,937	USD	366
2016-07-01 to 2016-09-30	-20,195,483	USD	92
2016-04-01 to 2016-06-30	-18,226,540	USD	91
2016-01-01 to 2016-03-31	-15,450,618	USD	91
2015-01-01 to 2015-12-31	-34,283,702	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-12-31	138,362,160	USD
At 2016-12-31	124,597,233	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-12-31	35,405,426	USD
At 2016-12-31	43,823,027	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2017-12-31	10,513,371	USD
At 2016-12-31	10,513,371	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2017-12-31	6,009,729	USD
At 2016-12-31	7,628,394	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-12-31	6,003,205	USD
At 2016-12-31	15,821,511	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	31,675,023	USD	92
2017-01-01 to 2017-12-31	125,862,987	USD	365
2017-07-01 to 2017-09-30	31,830,014	USD	92
2017-04-01 to 2017-06-30	30,047,857	USD	91
2017-01-01 to 2017-03-31	32,310,093	USD	90
2016-10-01 to 2016-12-31	30,877,248	USD	92
2016-01-01 to 2016-12-31	111,604,298	USD	366
2016-07-01 to 2016-09-30	32,735,946	USD	92
2016-04-01 to 2016-06-30	24,430,331	USD	91
2016-01-01 to 2016-03-31	23,560,773	USD	91
2015-01-01 to 2015-12-31	74,855,813	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	24,641,124	USD	92
2017-01-01 to 2017-12-31	98,572,618	USD	365
2017-07-01 to 2017-09-30	25,510,239	USD	92
2017-04-01 to 2017-06-30	23,878,751	USD	91
2017-01-01 to 2017-03-31	24,542,504	USD	90
2016-10-01 to 2016-12-31	23,911,731	USD	92
2016-01-01 to 2016-12-31	88,712,035	USD	366
2016-07-01 to 2016-09-30	26,980,343	USD	92
2016-04-01 to 2016-06-30	19,630,801	USD	91
2016-01-01 to 2016-03-31	18,189,160	USD	91
2015-01-01 to 2015-12-31	57,791,923	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-12-31	90,357,644	shares
At 2016-12-31	74,062,370	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-12-31	665,775,504	USD
At 2016-12-31	556,718,356	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-12-31	-117,005	USD
At 2016-12-31	1,327,968	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2017-12-31	142,488,809	USD
At 2016-12-31	123,378,420	USD
At 2015-12-31	175,933,053	USD
At 2014-12-31	111,537,594	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-12-31	25,426,733	USD
At 2016-12-31	14,281,627	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-12-31	7,106,557	USD
At 2016-12-31	5,256,181	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-12-31	6,009,729	USD
At 2016-12-31	7,628,394	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-12-31	2,639,354	USD
At 2016-12-31	2,113,147	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-12-31	8,611,892	USD
At 2016-12-31	6,368,389	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-12-31	2,600,906	USD
At 2016-12-31	1,749,059	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2017-12-31	1,952,000	USD
At 2016-12-31	4,926,000	USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

Period	Value	Unit	Days
At 2017-12-31	24,766	USD
At 2016-12-31	174,793	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-88,205,772	USD	365
2016-01-01 to 2016-12-31	-73,740,339	USD	366
2015-01-01 to 2015-12-31	-31,200,603	USD	365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-88,205,772	USD	365
2016-01-01 to 2016-12-31	-73,740,339	USD	366
2015-01-01 to 2015-12-31	-29,102,837	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-89,650,745	USD	365
2016-01-01 to 2016-12-31	-75,120,710	USD	366
2015-01-01 to 2015-12-31	-26,227,877	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-89,012,591	USD	365
2016-01-01 to 2016-12-31	-73,740,339	USD	366
2015-01-01 to 2015-12-31	-29,909,197	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	8,033,899	USD	92
2017-01-01 to 2017-12-31	28,290,369	USD	365
2017-07-01 to 2017-09-30	6,319,775	USD	92
2017-04-01 to 2017-06-30	6,169,106	USD	91
2017-01-01 to 2017-03-31	7,767,589	USD	90
2016-10-01 to 2016-12-31	6,965,517	USD	92
2016-01-01 to 2016-12-31	23,892,263	USD	366
2016-07-01 to 2016-09-30	5,755,603	USD	92
2016-04-01 to 2016-06-30	5,799,530	USD	91
2016-01-01 to 2016-03-31	5,371,613	USD	91
2015-01-01 to 2015-12-31	18,063,890	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	1,850,376	USD	365
2016-01-01 to 2016-12-31	1,708,498	USD	366
2015-01-01 to 2015-12-31	1,048,431	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	1,618,665	USD	365
2016-01-01 to 2016-12-31	1,377,466	USD	366
2015-01-01 to 2015-12-31	870,199	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2017-01-01 to 2017-12-31	USD	365
2016-01-01 to 2016-12-31	USD	366
2015-01-01 to 2015-12-31	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	0	USD	365
2016-01-01 to 2016-12-31	0	USD	366
2015-01-01 to 2015-12-31	-2,098,000	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	94,347,922	USD	365
2016-01-01 to 2016-12-31	6,295,761	USD	366
2015-01-01 to 2015-12-31	81,902,363	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-9,818,306	USD	365
2016-01-01 to 2016-12-31	8,521,899	USD	366
2015-01-01 to 2015-12-31	4,497,225	USD	365

Inspect the source

Entity: INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured: 2026-09-20T05:17:43.559Z
SEC response SHA-256: 9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))